Adenotonsillectomy. Enlargement of tonsils, Enlargement of adenoids
Conditions
Interventions
Intervention 1: Intervention group 1: Syrup Ibuprofen 10mg/ kg orally, once an hour before surgery and then every 6 hour for 3 days was used. This syrup manufacturing company is Hakim co. in Iran and
Treatment - Drugs
Intervention group 1: Syrup Ibuprofen 10mg/ kg orally, once an hour before surgery and then every 6 hour for 3 days was used. This syrup manufacturing company is Hakim co. in Iran and its concentratio
Intervention group 2: Syrup Acetaminophen 15mg/ kg orally, once an hour before surgery and then every 6 hours for 3 days was used. This syrup manufacturing company is Kimidaru co. in Iran and its conc
Sponsors
Vice chancellor for research, Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
4 Years to 10 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1- No Allergy to Non Steroid Anti-Inflammatory Drugs 2- No History of coagulopathy 3- No Renal and Hepatic disorder 4- No Severe Asthma (recently admission or treatment with oral corticosteroid) 5- No Family history of coagulopathy 6- No Evidence of Mental retardation Exclusion Criteria: 1- Severe and uncontrollable bleeding during and after surgery 2- Severe pain after surgery which needs additional analgesic
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score. Timepoint: Six hours postoperative, at the end of first postoperative day, at the end of second postoperative day. Method of measurement: with visual analogue pain scale (1-10 score). | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative bleeding volume. Timepoint: During the surgery. Method of measurement: Amount of bleeding in CC, according to the number of sterile gases that is used during the surgery and amount of blood at suction bottle.;Bleeding at the first postoperative day. Timepoint: At the end of the first postoperative day. Method of measurement: questionnaire.;Bleeding during the first postoperative week. Timepoint: At the end of first postoperative week. Method of measurement: questionnaire.;Nausea. Timepoint: At the end of first postoperative day and at the end of first postoperative week. Method of measurement: questionnaire.;Vomiting. Timepoint: At the end of first postoperative day and at the end of first postoperative week. Method of measurement: questionnaire.;Time to start eating of oral liquids. Timepoint: At the end of first postoperative week. Method of measurement: questionnaire.;Time to start eating of semisolid foods. Timepoint: At the end of first postoperative week. Method of measurement: questionnaire.;Time to start eating of solid foods. Timepoint: At the end of first postoperative week. Method of measurement: questionnaire.;Time to going back to their normal life. Timepoint: At the end of first postoperative week. Method of measurement: questionnaire.;Overall satisfaction of recovery. Timepoint: At the end of first postoperative week. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Mirashrafi
ENT research center, Imam Khomeini Hospital
Outcome results
None listed